(Q37946441)

25 August 2017

title

Adherence to adjuvant therapy in post-menopausal breast cancer patients: a review (English)

1 reference

25 August 2017

1 reference

M Banning

1

1 reference

25 August 2017

language of work or name

English

0 references

publication date

18 October 2011

1 reference

European Journal of Cancer Care

25 August 2017

published in

1 reference

25 August 2017

volume

21

1 reference

25 August 2017

issue

1

1 reference

25 August 2017

page(s)

10-19

1 reference

Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2354.2011.01295.X

Intentional and non-intentional non-adherence to medication amongst breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2354.2011.01295.X

Predictors of medication adherence in the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2354.2011.01295.X

Older people and adherence with medication: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2354.2011.01295.X

A review of interventions used to improve adherence to medication in older people

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2354.2011.01295.X

Prevention and treatment of side-effects of systemic treatment: bone loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2354.2011.01295.X

Choosing early adjuvant therapy for postmenopausal women with hormone-sensitive breast cancer: aromatase inhibitors versus tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2354.2011.01295.X

Quality of life of postmenopausal women in the ATAC ("Arimidex", tamoxifen, alone or in combination) trial after completion of 5 years' adjuvant treatment for early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2354.2011.01295.X

Aromatase inhibitors: a new reality for the adjuvant endocrine treatment of early-stage breast cancer in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2354.2011.01295.X

A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2354.2011.01295.X

Lifestyle habits as a contributor to anti-cancer treatment failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2354.2011.01295.X

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2354.2011.01295.X

Cancer treatment adherence among low-income women with breast or gynecologic cancer: a randomized controlled trial of patient navigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2354.2011.01295.X

Patient beliefs and tamoxifen discontinuance in older women with estrogen receptor--positive breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2354.2011.01295.X

Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2354.2011.01295.X

Prescription drug cost sharing: associations with medication and medical utilization and spending and health.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2354.2011.01295.X

Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA.17.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2354.2011.01295.X

Adherence beliefs among breast cancer patients taking tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2354.2011.01295.X

Target and reality of adjuvant endocrine therapy in postmenopausal patients with invasive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2354.2011.01295.X

Improving compliance and persistence to adjuvant tamoxifen and aromatase inhibitor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2354.2011.01295.X

Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2354.2011.01295.X

Reducing the risk for breast cancer recurrence after completion of tamoxifen treatment in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2354.2011.01295.X

Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2354.2011.01295.X

Risk of early recurrence among postmenopausal women with estrogen receptor-positive early breast cancer treated with adjuvant tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2354.2011.01295.X

Adherence to tamoxifen over the five-year course

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2354.2011.01295.X

Predictors of tamoxifen discontinuation among older women with estrogen receptor-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2354.2011.01295.X

Adherence to therapy with oral antineoplastic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2354.2011.01295.X

Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2354.2011.01295.X

Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2354.2011.01295.X

Aromatase inhibitors for breast cancer: different structures, same effects?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2354.2011.01295.X

Patient adherence and persistence with oral anticancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2354.2011.01295.X

Adjuvant tamoxifen prescription in women 65 years and older with primary breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2354.2011.01295.X

Effects of toremifene and tamoxifen on lipid profiles in post-menopausal patients with early breast cancer: interim results from a Japanese phase III trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2354.2011.01295.X

American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2354.2011.01295.X

Oncologists' recommendations for adjuvant therapy in hormone receptor-positive breast cancer patients of varying age and health status

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2354.2011.01295.X

Adherence to adjuvant endocrine therapy in postmenopausal women with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2354.2011.01295.X

Five Years of Letrozole Compared With Tamoxifen As Initial Adjuvant Therapy for Postmenopausal Women With Endocrine-Responsive Early Breast Cancer: Update of Study BIG 1-98

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2354.2011.01295.X

10.1111/J.1365-2354.2011.01295.X

21 January 2018

Identifiers

DOI

1 reference

25 August 2017

1 reference